TMEM100 induces cell death in non-small cell lung cancer via the activation of autophagy and apoptosis
TMEM100 induces cell death in non-small cell lung cancer via the activation of autophagy and apoptosis
复制标题
DOI：
10.3892/or.2021.8014
复制
发表时间：
2021-05-01
期刊：
影响因子：
4.2
通讯作者：
He, Yujuan
中科院分区：
文献类型：
--
作者：
He, Qian;Dong, Yilin;He, Yujuan
肺癌是世界上最恶性的肿瘤之一。非小细胞肺癌(NSCLC)是最常见的肺癌类型，被定义为一种表现出遗传和细胞异质性的独特疾病。尽管在过去的二十年里，非小细胞肺癌的治疗取得了重大进展，但非小细胞肺癌患者的5年存活率仍然很高。
Lung cancer is one of the most malignant type of tumors worldwide. Non-small cell lung cancer (NSCLC), which is the most common type of lung cancer, is defined as a distinct disease that exhibits both genetic and cellular heterogeneity. Although in the past two decades significant advances in the treatment of NSCLC have besen performed, the 5-year survival rate of patients with NSCLC remains